60 Day FRN

Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices

Centers for Disease Control and
Prevention
[60Day–22–1317; Docket No. CDC–2022–
0107]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled, National
Healthcare Safety Network (NHSN)
Coronavirus (COVID–19) Surveillance
in Healthcare Facilities. Data collected
through this version of NHSN is
intended to inform the federal
government’s understanding of disease
patterns, including the changing burden
of disease, and develop policies for
prevention and control of problems
related to COVID–19.
DATES: CDC must receive written
comments on or before November 14,
2022.
SUMMARY:

You may submit comments,
identified by Docket No. CDC–2022–
0107 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.

lotter on DSK11XQN23PROD with NOTICES1

ADDRESSES:

VerDate Sep<11>2014

17:06 Sep 09, 2022

Jkt 256001

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Proposed Project
National Healthcare Safety Network
(NHSN) Coronavirus (COVID–19)
Surveillance in Healthcare Facilities
(OMB Control No. 0920–1317, Exp. 1/

PO 00000

Frm 00037

Fmt 4703

Sfmt 4703

55815

31/2024)—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Hospitals are key partners in the U.S.
response to COVID–19. The response is
locally executed, state managed, and
federally supported. At the federal level,
the U.S. Department of Health & Human
Services (HHS) COVID–19 Response
Function, the White House Coronavirus
Response Team, and the Centers for
Disease Control & Prevention (CDC)
COVID–19 Response Function work
together to support the effective
operations of the American healthcare
system. This collection initially began
in March 2020 through a letter from
then Vice President Pence to the
nation’s 4,700 hospitals, asking them to
submit data daily on the number of
patients tested for COVID–19, as well as
information on bed capacity and
requirements for other supplies.
(https://www.cms.gov/files/document/
32920-hospital-letter-vice-presidentpence.pdf). CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290)
was approved March 26, 2020 for the
collection of hospital COVID–19 data.
The NHSN COVID–19 Module also
collects COVID–19 data from long-term
care facilities and dialysis centers
(collection was later revised and given
OMB Control No. 0920–1317).
Beginning July 2020, at the request of
the White House Coronavirus Task
Force, the collection of COVID–19 data
from hospitals was moved to HHS/
ASPR and housed in the TeleTracking
portal. Collection of data from the other
facilities remained with CDC under the
NHSN COVID–19 Module.
Beginning in mid-December 2022,
NHSN will resume the responsibility for
collection of COVID–19 hospital data
and will incorporate the TeleTracking
data collection into 0920–1317. The
purpose of this Revision request is to
move the burden associated with
collection of COVID–19 related data
from hospitals to the CDC NHSN
COVID–19 module. CDC requests OMB
approval for an estimated 8,467,590
annual burden hours. 3,290,200 in
burden hours will be added to this
previous collection for the addition of
the TeleTracking portal. There are no
additional costs to respondents other
than their time to participate.

E:\FR\FM\12SEN1.SGM

12SEN1

55816

Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name

LTCF personnel ................................

NHSN and Secure Access Management Services (SAMS) enrollment.
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
LTCF VA Resident COVID–19
Event Form.
LTCF VA Staff and Personnel
COVID–19 Event Form.
Weekly Healthcare Personnel
COVID–19 Vaccination Cumulative Summary.
Weekly Resident COVID–19 Vaccination Cumulative Summary for
Long-Term Care Facilities.
Weekly Patient COVID–19 Vaccination Cumulative Summary for Dialysis Facilities.
Monthly Reporting Plan form for
Long-term Care Facilities.

LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................

Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................

Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
LTCF personnel ................................
Facility personnel ..............................

lotter on DSK11XQN23PROD with NOTICES1

Number of
respondents

Type of respondent

LTCF personnel ................................
Microbiologist (IP) .............................
LTCF personnel ................................

VerDate Sep<11>2014

17:06 Sep 09, 2022

Jkt 256001

PO 00000

Frm 00038

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
hours

11,500

1

60/60

11,500

11,621

52

40/60

402,861

1,870

52

40/60

64,827

1,870

52

40/60

64,827

5,811

1

40/60

3,874

935

1

40/60

623

935

1

40/60

623

11,621

52

15/60

151,073

1,870

52

15/60

24,310

1,870

52

15/60

24,310

5,811

1

15/60

1,453

935

1

15/60

234

935

1

15/60

234

11,621

52

10/60

100,715

1,870

52

10/60

16,207

1,870

52

10/60

16,207

188

36

35/60

3,948

188

36

20/60

2,256

12,600

52

90/60

982,800

16,864

52

75/60

1,096,160

7,700

52

75/100

500,500

16,864

9

5/60

12,648

E:\FR\FM\12SEN1.SGM

12SEN1

55817

Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name

Microbiologist (IP) .............................

Healthcare Personnel Safety Monthly Reporting Plan—completed by
Dialysis Facilities.
Healthcare Personnel Safety Monthly Reporting Plan—completed by
Inpatient Psychiatric Facilities.
COVID–19 Dialysis Component
Form.
NHSN COVID–19 Hospital Module
NHSN COVID–19 Hospital Module

Microbiologist (IP) .............................
Microbiologist (IP) .............................
Hospitals ...........................................
Infusion Centers and Outpatient
Clinics reporting Inventory & use
of therapeutics (MABs).

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–19562 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund Addis
Ababa City Administration Health
Bureau of Ethiopia
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000 for
Year 1 of funding to the Addis Ababa
City Administration Health Bureau of
Ethiopia (AACAHB) to ensure
continuity of quality comprehensive
HIV/AIDS prevention, care, and
treatment services for controlling the
HIV epidemic activities in Addis Ababa
City Administration of Ethiopia. The
award will help the city close gaps to
achieve the 95–95–95 goals (95% of
HIV-positive individuals knowing their
status, 95% of those receiving ART
[Antiretroviral therapy], and 95% of
those achieving viral suppression) and
reach HIV epidemic control. Funding
amounts for years 2–5 will be set at
continuation.

SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Number of
respondents

Type of respondent

The period for this award will be
September 30, 2022 through September
29, 2027.

DATES:

VerDate Sep<11>2014

17:06 Sep 09, 2022

Jkt 256001

5/60

5,775

394

12

5/60

394

4,900

104

20/60

169,867

6,000
400

365
52

90/60
15/60

3,285,000
5,200

Summary of the Award
Recipient: Addis Ababa City
Administration Health Bureau of
Ethiopia.
Purpose of the Award: The purpose of
this award is to ensure continuity of
quality comprehensive HIV/AIDS
prevention, care, and treatment services
for controlling the HIV epidemic
activities in Addis Ababa City
Administration of Ethiopia. This NOFO
will help the city close gaps to achieve
the 95–95–95 goals and reach HIV
epidemic control.
Amount of Award: The approximate
year 1 funding amount will be
$10,000,000 in Federal Fiscal Year
(FFY) 2022 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Period of Performance: September 30,
2022 through September 29, 2027.

Fmt 4703

Sfmt 4703

Total
burden
hours

9

Tesfaye Desta, Center for Global Health,
Centers for Disease Control and
Prevention, U.S. Embassy—Addis
Ababa, Entoto Road, Addis Ababa,
Ethiopia, Telephone: 800–232–6348,
Email: [email protected].
SUPPLEMENTARY INFORMATION: The
single-source award will implement
prevention, testing and counselling,
prevention of mother to child
transmission, care and treatment,
laboratory, Strategic Information (M&E,
Surveillance, HIS), TB/HIV and other
public health need affecting HIV/AIDS
programming like COVID in the capital
city of Ethiopia, Addis Ababa.
The purpose of this award is to
continue supporting the strengthening
of public health response and programs,
including but not limited to HIV/AIDS,
in the Addis Ababa City. AACAHB is
the only government entity with a legal
authority and mandate to plan, manage,
administer, and coordinate all healthrelated activities in the city.

Frm 00039

Average
burden per
response
(in hours)

7,700

FOR FURTHER INFORMATION CONTACT:

PO 00000

Number of
responses per
respondent

Authority: Public Law 108–25 (the
United States Leadership Against HIV
AIDS, Tuberculosis and Malaria Act of
2003).
Dated: September 6, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–19566 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
RFA–OH–22–003, Occupational Safety
and Health Training Project Grants
(TPG).
Date: December 6, 2022.
Time: 1:00 p.m.–4:00 p.m., EST.

E:\FR\FM\12SEN1.SGM

12SEN1